CTRI/2023/10/059161已完成不适用
Effect of multi-component intervention on medication adherence among non-adherent type 2 diabetic patients in an urban area of South India. A cluster randomized control trial.
Saveetha medical College1 个研究点 分布在 1 个国家目标入组 124 人开始时间: 2023年6月11日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 124
- 试验地点
- 1
- 主要终点
- Blood glucose level (mg/dl)
研究概览
简要总结
Diabetes is one of the most significant health problem and the most common chronic metabolic disease in the world and it is expected to be the 7th leading cause of death worldwide by 2030. There are only few interventional studies related to medication non adherence among type 2 Diabetes Mellitus patient in south India, hence this study has been done to evaluate the effectiveness of multicomponent intervention on medication non adherence in type 2 Diabetes Mellitus.
I will sent for publication once the trial is completed
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- Participant Blinded
入排标准
- 年龄范围
- 18.00 Year(s) 至 80.00 Year(s)（—）
- 性别
- All
入选标准
- •Adult individuals with Type 2 Diabetes mellitus over 18 years of age.
- •Old and newly diagnosed Type 2 diabetic patients.
- •Patients who were found to be non-adherent by MAQ scores of 1-4 presenting to the study setting for further management will be included in the study.
排除标准
- •Person not willing to participate in the study.
- •Pregnant, lactating and trying to become pregnant.
- •Malignancy or life-threatening diseases.
结局指标
主要结局
Blood glucose level (mg/dl)
时间窗: 6months
次要结局
- Blood glucose level (mg/dl)(0 and 3rd month of study)
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
2 期
Novel Chinese Medicine Formula for DiabetesType 2 DiabetesNCT06978023Chinese University of Hong Kong162
招募中
4 期
Comparison of Dapagliflozin, Lobeglitazone, and Its Combination in Efficacy and SafetyDiabetes Type 2NCT05915949Seoul National University Bundang Hospital99
进行中（未招募）
不适用
Effect of a Pharmacist-led, Collaborative Practice on Clinical Outcomes in Persons with DiabetesType2diabetesDiabetesNCT05995262Methodist Health System100
招募中
2 期
Nitazoxanide as Adjuvant Therapy in Type 2 Diabetes MellitusDiabetes Mellitus, Type 2NCT06010992Tanta University70
招募中
Unknown
Comparative study of efficacy, safety and patient compliance of Dapagliflozin(anti diabetic drug) and Metformin(anti diabetic drug) Vs Vildagliptin(anti diabetic drug) and Metformin combination therapy in newly diagnosed Type 2 diabetes patientsType 2 diabetes mellitus without complications,CTRI/2020/12/030147Kumar Gautam180